Cerule’s extracts come from an ancient source—cyanobacteria. Cyanobacteria, microscopic blue-green algae that have inhabited the earth for at least 3 billion years, literally gave us life and continue to support human health and well-being. Cyanobacteria, including both Spirulina and AFA, are the forms of blue-green algae from which Cerule’s products are derived.
Through pre-clinical and clinical studies, Cerule has studied the bioactive properties of blue-green algae in order to identify the mechanisms of action and condition-specific benefits hidden within.
Cerule’s processes and technologies turn yesterday’s algal powders into today’s Algaceuticals. Cerule’s standardized extracts maximize key bioactives to deliver proven health benefits.
Our innovative harvesting, extracting, filtering and drying technologies concentrate and preserve the nutritional properties of our products, resulting in highly efficacious extracts.
Cerule, a trusted provider of scientifically researched, high-quality, microalgae ingredients, has launched Cyactiv.com for direct to consumer solutions that address whole-body inflammation. More ›
As recently published in the Journal of Medicinal Food, Jensen et al. set out to characterize the basic biological properties of Cyactiv, which contains a known anti-inflammatory cyclooxygenase-2 (COX-2) inhibitor phycocyanin (PC), as well as a high level of non- phycocyanin bioactive compounds. More ›
Desert Lake Technologies announced today that it plans to operate under the name Cerule®. The new name more closely unifies its scientifically researched, microalgae-based ingredients with the company that supports it. The name change is effective immediately and will be showcased at next week’s SupplySide West Global Expo and Conference in Las Vegas, Nevada. More ›